Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data.

E. Papathanassiou (Athens , Greece), A. Papaioannou (Athens, Greece), G. Hillas (Athens, Greece), E. Mizi (Athens , Greece), P. Bakakos (Athens, Greece), V. Apollonatou (Athens, Greece), G. Verykokou (Athens, Greece), N. Roussakis (Athens, Greece), Z. Tsilogianni (Athens, Greece), K. Kostikas (Athens, Greece), S. Papiris (Athens, Greece), S. Loukides (Athens, Greece)

Source: International Congress 2018 – Biomarkers for evaluating COPD
Session: Biomarkers for evaluating COPD
Session type: Thematic Poster
Number: 1079
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papathanassiou (Athens , Greece), A. Papaioannou (Athens, Greece), G. Hillas (Athens, Greece), E. Mizi (Athens , Greece), P. Bakakos (Athens, Greece), V. Apollonatou (Athens, Greece), G. Verykokou (Athens, Greece), N. Roussakis (Athens, Greece), Z. Tsilogianni (Athens, Greece), K. Kostikas (Athens, Greece), S. Papiris (Athens, Greece), S. Loukides (Athens, Greece). Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data.. 1079

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: